176 related articles for article (PubMed ID: 21976106)
21. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
[TBL] [Abstract][Full Text] [Related]
22. How well do serum sTREM-1 measurements prognosticate in septic shock?
Phua J; Koay ES; Zhang D; Lee KH
Anaesth Intensive Care; 2008 Sep; 36(5):654-8. PubMed ID: 18853582
[TBL] [Abstract][Full Text] [Related]
23. Value of sTREM-1, procalcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis.
Palmiere C; Bardy D; Mangin P; Augsburger M
J Infect; 2013 Dec; 67(6):545-55. PubMed ID: 24012914
[TBL] [Abstract][Full Text] [Related]
24. Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease.
Shu CC; Lee LN; Wu MF; Lee CH; Wang JT; Wang JY; Yu CJ;
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1415-20. PubMed ID: 22283904
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic value of procalcitonin and sTREM-1 levels in sepsis.
Halim B; Özlem T; Melek Ç; Münip Hakan Y; Cevval U; Gönül DH; Çiğdem Banu Ç
Turk J Med Sci; 2015; 45(3):578-86. PubMed ID: 26281323
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates.
Sarafidis K; Soubasi-Griva V; Piretzi K; Thomaidou A; Agakidou E; Taparkou A; Diamanti E; Drossou-Agakidou V
Intensive Care Med; 2010 May; 36(5):864-8. PubMed ID: 20232048
[TBL] [Abstract][Full Text] [Related]
27. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis.
Charles PE; Noel R; Massin F; Guy J; Bollaert PE; Quenot JP; Gibot S
BMC Infect Dis; 2016 Oct; 16(1):559. PubMed ID: 27729010
[TBL] [Abstract][Full Text] [Related]
28. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis.
Gibot S; Cravoisy A; Dupays R; Barraud D; Nace L; Levy B; Bollaert PE
Scand J Infect Dis; 2007; 39(6-7):604-8. PubMed ID: 17577825
[TBL] [Abstract][Full Text] [Related]
29. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
30. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis.
Saldir M; Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Babacan O; Erdem G; Kocak N; Sari E; Akgul EO; Kul M
Pediatr Neonatol; 2015 Dec; 56(6):415-21. PubMed ID: 26341458
[TBL] [Abstract][Full Text] [Related]
31. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.
Giamarellos-Bourboulis EJ; Mouktaroudi M; Tsaganos T; Koutoukas P; Spyridaki E; Pelekanou A; Kotzampassi K
J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631
[TBL] [Abstract][Full Text] [Related]
33. Clinical Association of a Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Patients with Systemic Lupus Erythematosus.
Bassyouni IH; Fawzi S; Gheita TA; Bassyouni RH; Nasr AS; El Bakry SA; Afifi N
Immunol Invest; 2017 Jan; 46(1):38-47. PubMed ID: 27648678
[TBL] [Abstract][Full Text] [Related]
34. Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever.
Lin CH; Yao M; Hsu SC; Ho CC; Lin MT; Lin CA; Hu FC; Yu CJ; Tien HF
Crit Care Med; 2011 May; 39(5):993-9. PubMed ID: 21283000
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and pentraxin 3 (PTX3) as markers of infection in febrile patients with systemic lupus erythematosus.
Kim J; Koh JK; Lee EY; Park JA; Kim HA; Lee EB; Garlanda C; Cotena A; Song YW
Clin Exp Rheumatol; 2009; 27(5):773-8. PubMed ID: 19917159
[TBL] [Abstract][Full Text] [Related]
36. New diagnostic and prognostic markers of ventilator-associated pneumonia.
Chastre J; Luyt CE; Trouillet JL; Combes A
Curr Opin Crit Care; 2006 Oct; 12(5):446-51. PubMed ID: 16943724
[TBL] [Abstract][Full Text] [Related]
37. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis.
Adly AA; Ismail EA; Andrawes NG; El-Saadany MA
Cytokine; 2014 Feb; 65(2):184-91. PubMed ID: 24290866
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers for risk stratification of febrile neutropenia among children with malignancy: a pilot study.
Mian A; Becton D; Saylors R; James L; Tang X; Bhutta A; Prodhan P
Pediatr Blood Cancer; 2012 Aug; 59(2):238-45. PubMed ID: 22535591
[TBL] [Abstract][Full Text] [Related]
39. The accuracy of C-reactive protein, procalcitonin, and s-TREM-1 in the prediction of serious bacterial infection in neonates.
Stein M; Schachter-Davidov A; Babai I; Tasher D; Somekh E
Clin Pediatr (Phila); 2015 May; 54(5):439-44. PubMed ID: 25294884
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers in fever and neutropenia: a solution in search of a problem?
Gea-Banacloche J
Crit Care Med; 2011 May; 39(5):1205-6. PubMed ID: 21610578
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]